“…Preclinical models aid in translating laboratory findings to clinical cognitive impairment and shed light on their underlying abnormal functions according to translational research [ 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 ]. Furthermore, by allowing the use of tailored treatments for memory-related disorders, this approach will contribute to the advancement of personalized medicine [ 71 , 75 , 76 , 77 , 78 , 79 , 80 , 81 ]. It also enables the investigation of structural changes in the brain and advances imaging techniques for clinical use [ 82 , 83 ].…”